AstraZeneca’s Profit Boosted by Its Blockbuster Cancer Drugs
· bloomberg.com · popularity 38/100 · 0 similar stories today · Cancer & Oncology (Health & Life Sciences)
Read the original at bloomberg.com →
Summary
AstraZeneca Plc profit rose more than expected in the third quarter, driven by its booming oncology business. Earnings per share, excluding some …
Found in: Bloomberg. Rating basis: single outlet; outlet tier 5; 1 feeds; feed position 7.